Brief Det~nitive Report

Similar documents
Cell Interactions Between Histoincompatible T and B Lymphocytes. The H-2

delayed-type hypersensitivity [T cell (thymus-derived)/macrophlage/ir gene/cell-mediated immunity/altered self]

From the Walter and Eliza Hall Institute of Medical Research, P.O. Royal Melbourne Hospital, Melbourne 3050 Australia

Mixed chimerism and split tolerance: Mechanisms and clinical correlations

PRODUCTION OF AUTO-ANTI-IDIOTYPIC ANTIBODY DURING

Immunogenetic Control of the Response of Female Mice to Male Tissue Grafts. Jane S. Schultz L 2, Roberta DeMott-Friberg ~, and Theodore F.

EVIDENCE FOR THE EXPRESSION OF Ia (H-2-ASSOCIATED) ANTIGENS ON THYMUS-DERIVED LYMPHOCYTES"

T cell regulation, anti-idiotypic immunity, and the nephritogenic immune response

Strategies for Assessment of Immunotoxicology in Preclinical Drug Development

Brief Definitive Reports

CHAPTER 7 CELLULAR BASIS OF ANTIBODY DIVERSITY: CLONAL SELECTION

IMMUNE RESPONSE GENES CONTROL T KILLER CELL RESPONSE AGAINST MOLONEY TUMOR ANTIGEN CYTOLYSIS REGULATING REACTIONS AGAINST THE

Virus-Infected L Cells

At the conclusion of this lesson you should be able to:

Antibody-based HLA (Human Leucocyte Antigen ) tissue-typing technologies

Immunological Surveillance against DNA Virus-Transformed Cells:

Chapter 2. Antibodies

**MATERIAL SAFETY DATA SHEET**

INDUCTION OF B CELL TOLERANCE IN VITRO TO 2,4-DINITRO- PHENYL COUPLED TO A COPOLYMER OF D-GLUTAMIC ACID AND I)-LYSINE (DNP-D-GL)*

CELL-MEDIATED IMMUNITY AND BLOCKING SERUM ACTIVITY TO TOLERATED ALLOGRAFTS IN RATS*

Cytotoxic T-Lymphocyte Epitope Immunodominance in the Control of Choroid Plexus Tumors in Simian Virus 40 Large T Antigen Transgenic Mice

Course Descriptions. BIOL: Biology. MICB: Microbiology. [1]

Platelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD

Development of NOG mice

Histocompatibility. Revised and effective July 14, Histocompatibility Standard 1 (HC S1)

antisera are described in ref. 11. All the present studies were done with MT. 1, a spontaneous C3H/Umc mammary adenocarcinoma

Immunogenicity of Stem Cells in Therapeutic Applications. MDPB-Registry meeting nov 25th Stem cell immunogenicity in therapeutic applications

Des cellules-souches dans le poumon : pourquoi faire?

Effective control of acute pathogens is usually mediated

PROTOCOL FOR A RESEARCH SAMPLE REPOSITORY FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, OTHER CELLULAR THERAPIES AND MARROW TOXIC INJURIES

INFECTIOUS MURINE TYPE-C VIRUSES RELEASED FROM HUMAN CANCER CELLS TRANSPLANTED INTO NUDE MICE

Foreign serum-induced bile duct lesion (BDL) in athymic BALBIc nude mice

Genetic Engineering 1

produce LT under stimulation by mitogen or TNP-coupled

(From the Department of Medical Microbiology, University of Wisconsin, Madison, Wisconsin 53706)

Virus-Infected Mice. Alabama the host before antibody transfer. This suggests

Centro di Studi Nucleari della Casaccia, Roma Laboratorio di Radiopatologia, Gruppo CNEN-Euratom di Immunogenetica

BY VILHO J. PASANEN,* RICHARD ASOFSKY, AND PHILLIP J. BAKER

The promise of T cell engineering CD19 CAR therapy A prologue to immune regenerative medicine Vast potential, patience, public education

Introduction to Cell- Biomaterial Engineering!

ABSENCE OF THE Lyt-2-,L3T4 + LINEAGE OF T CELLS IN MICE TREATED NEONATALLY WITH ANTI-I-A CORRELATES WITH ABSENCE OF INTRATHYMIC

VARIANTS OBTAINED BY MUTAGENESIS OF MOUSE MASTOCYTOMA I. Rejection by Syngeneic Mice. By CATHERINE UYTTENHOVE,* JACQUES VAN SNICK,* AND THIERRY BOON

HSV-2 therapeutic vaccine program. Subunit vaccine candidates

Visit the HI3 website. ucdenver.edu/humanimmunology

repeating antigenic determinants, require both thymus- and

Summary. Materials and Methods

Anergy and Exhaustion Are Independent Mechanisms of Peripheral T Cell Tolerance By Benedita Rocha,* Alf Grandien,~ and Antonio A.

AUTOIMMUNE HEPATITIS EXPERIMENTAL MODEL BASED ON. Sainte-Justine University Hospital, Montreal (Quebec), H3T 1C5, Canada; 3 Departments

ANTIBODY IMMUNOGENICITY

differentiation of thymic epithelial progenitors

Overview. Models in laboratory research. The unique position of the mouse as a model. Mouse genetics 101. Genetic engineering for hypothesis testing

Sovaldi Pegasys Ribavirin

Immunotherapy in myeloma

EBOLA: niente si trasmette come la paura. La biologia del virus Ebola

4000: Cellular Therapy Essential Data Pre- Infusion

CAP Accreditation Checklists 2017 Edition

Blood Product Utilization

Blue Marble University Biology Course Handbook

Transplantation tolerance correlates with high levels of T- and B-lymphocyte activity

REGISTRATION DOCUMENT FOR RECOMBINANT DNA RESEARCH

Issues in production of viral gene transfer vectors. Stefan Kochanek Department of Gene Therapy Ulm University

FACT - CIBMTR Data Audit Collaboration

Immunogenetics ~) 1979 by Springer-Ver/ag New York Inc.

Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A

MATERIAL SAFETY DATA SHEET

Insight to Gene Techno Science Co.,Ltd

B Lymphocyte Memory: Role of Stromal Cell Complement and Fc RIIB Receptors

Myeloma treatment algorithm 1999

Split-Operon Control of a Prophage Gene*

HL-A Model of the H-2 system?

Two separate pathways have evolved for the presentation of

Treatment strategies for relapsing and refractory myeloma

2054, Chap. 13, page 1

Mouse Strain Resistant to N-, B-, and NB-Tropic Murine Leukemia Viruses

Antigen-specific drug-targeting used to manipulate an immune response in vivo (suppression/cytarabine/cytotoxicity/toxogen)

The World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.

New Hearts for Old The Story of Transplantation. Changes in view of human body

Tutorial for Completing Penn s r s DNA Registration Document

19/02/2018. Transplant Webinar Series: Ep. 3 Donor Selection For Solid Organ Transplants Is A Virtual Crossmatch Better Than Real?

ABO Typing Discrepancies

This talk will cover. Treatment for relapsed and/or refractory myeloma. What is relapsed myeloma and refractory myeloma. Treatment options for relapse

Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust. Natural course of myeloma. Some definitions. First relapse.

Separation of antibody helper and antibody suppressor human T

Supplementary Figure 1

The New News in Stem Cell Research Andrés Bratt-Leal, PhD 12/1/2017

Stem Cells. Part 1: What is a Stem Cell? STO Stem cells are unspecialized. What does this mean?

Introducing new DNA into the genome requires cloning the donor sequence, delivery of the cloned DNA into the cell, and integration into the genome.

Methods and Materials

Medical Issues in a Clinical Cellular Therapy Laboratory. Kala Mohandas, MD Director, Cellular Therapy Lab Montefiore Medical Center Bronx, NY

Three Methods for Phase I/II Clinical Trials, with Application to Allogeneic

Regulatory Pathways for Rare Diseases

Lymphoid dendritic cells are potent stimulators of the primary

chronic leukemia lymphoma myeloma differentiated 14 September 1999 Transformed Pre- Ig Surface Surface Secreted B- ALL Macroglobulinemia Myeloma

Xeno-Free Systems for hesc & hipsc. Facilitating the shift from Stem Cell Research to Clinical Applications

Transcription:

Brief Det~nitive Report THYMIC RECONSTITUTION OF NUDE F MICE WITH ONE OR BOTH PARENTAL THYMUS GRAFTS* BY ROLF M. ZINKERNAGEL, A. ALTHAGE, AND G. CALLAHAN From the Departments of Immunopathology and of Molecular Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037 Thymus-derived lymphocytes (T cells) have two outstanding characteristics that distinguish them from other lymphocytes: (a) they express two specificities, one for self-antigens, the major transplantation antigens (H) coded by the major histocompatibility gene complex (MHC), and a second specificity for foreign antigenic determinants. (b) T cells must undergo differentiation or maturation in the thymus (, 2). Apparently, an important step in T-cell differentiation in the thymus is the selection of T-cells' restriction specificity for self-h. This interpretation stems from experiments with chimeras formed by lethally irradiating parental type mice and reconstituting them with F stem cells: the maturing F T cells expressed predominantly the restriction specificities for the recipient parental MHC type (3-8). Alternatively, adult F mice that were thymectomized, lethally irradiated, reconstituted with bone marrow, and then engrafted with a parental thymus had T cells that were restricted predominantly to the thymus donors' H-2 (-8). The present study first extends these observations to nude mice that are born without a thymus and therefore do not develop functional T cells and second, attempts to study the possibility that suppression may be responsible for the apparent influence of the radioresistant portion of the thymus on T-cell restriction specificities. We tested the immunocompetence and restriction specificities expressed by lymphocytes from F nude mice reconstituted with both parental thymus grafts; our expectation was that suppression of the expression of T-cell restriction specificity should result either in complete immunoincompetence or emergence of only one of the two possible sets of restriction specificities. Nude F mice that simultaneously received thymus gratis from both parents developed spleen cells restricted to both parental H-2 types. These results are compatible with the idea that the thymus' influence on T-cell restriction is via positive selection rather than by suppression. Materials and Methods Mice. BALB/c nu/nu female mice were purchased from the nude mice breeding facility of the University of California at San Diego thanks to the generosity of Dr. G. Sato and D. Mackensen. These mice have been described in references 9 and 0. The (C57BL/6 X BALB/ c)fl nu/nu mice were derived from fifth backcross generation C57BL/6 nu/+ and seventh backcross generation BALB/c nu/nu; they were generously donated by Doctors J. Hedrick and J. Watson (,2). None of the nude mice generated detectable virus-specific cytotoxic T cells. * Publication No. 755 from the Departments of Immunopathology and Molecular Immunology, Scripps Clinic and Research Foundation, La Jolla, Calif. Supported by U. S. Public Health Service grants A-3775 and A-00273. J. Exp. MED. The Rockefeller University Press 0022-007/79/09/693/05 $.00 693 Volume 50 September 979 693-697

69 ZINKERNAGEL ET AL. BRIEF DEFINITIVE REPORT To form thymus chimeras, 6- to 8-wk-old nude mice were transplanted with thymus grafts from 5- to 7-d-old fetuses under the kidney capsule. Several protocols were tried. The only successful method for obtaining nude F mice with functional grafts of both parents was to transplant 5- to 7-d-old fetal thymus lobes from one parental strain under the left kidney capsule and from the other parental strain under the right kidney capsule on the same day. When, instead, F nude mice were transplanted first with either BALB/c or C57BL/6 fetal (7-9 d) thymus lobes and - wks later received the second parental grafts, only the first grafts were functional. Similarly, if one parental graft was older (e.g., <2 h after birth) than the other one (6- to 8-d-old fetal grafts), only the older graft was histologically intact and functional; the younger graft left a connective tissue scar in the recipients kidney. In all cases the functional test and the observed restriction specificity of mature T cells correlated with the engrafted and histologically normal thymus. Virus, Immunization, 5Cr-Release Assay, and H-2 Typing Procedures. Nude mice reconstituted with thymus grafts for 5-20 wk or control mice were infected with ~5 06 plaque-forming units of vaccinia virus. Spleen cells from these mice were tested 6 d later for cytotoxic activity on vaccinia-infected or -uninfected target cells (, 3). The established fibroblast or fibrosarcoma cell lines from C3H origin (L929, H-2 ), BI0.D2 (D2, H-2o), and C57BL (MC57G, H-2 b) have been described previously (, 3). Test duration (6 or 6 h) and the percentage of spontaneous 5~Cr release are indicated in the table legends. Statistical comparisons used Student's t test. Each chimera was typed for H-2 as described previously (). Results and Discussion T cells from F nude mice reconstituted with thymus grafts from one parental strait are restricted in specificity to lyse only infected target cells sharing the H-2 type of th, donors' thymus (Table I, exp. 2). If suppression was directed against T-cell receptor: specific for self-h of the second parent in such thymically reconstituted mice, on, might expect that Fx nude mice that were reconstituted simultaneously with thymu: grafts from both parental strains would become immunoincompetent (caused b, reciprocal suppression of restriction specificities) or would express only one set of parental restriction specificities (the one that matures earliest or is dominant). To test this proposition, (C57BL/6 BALB/c) (H-2 b H-2a)F nude mice were transplanted on the same day with thymus lobes taken from fetuses of both parental strains; C57BL/6 lobes were inserted under each recipient's left kidney capsule, and BALB/c lobes were placed under the right kidney capsule (Table I, exp. ). Other (C57BL/6 BALB/c)F nude mice were grafted with fetal thymus lobes of either C57BL/6 or BALB/c origin (Table I, exp. 2). The transplant recipients were infected with vaccinia virus 8-0 wk later. 6 d after infection, virus-specific cytotoxic activity of the spleen cells was tested on appropriate target cells. Spleen cells from the transplanted mice with histologically normal grafts from both parents lysed infected target cells of both parental types (Table I, exp. I). Infected H-2 b and infected H-2 d targets were lysed about equally well. Spleen cells from unmanipulated control mice (C57BL and BALB/c) were about three times more active than those from the reconstituted nude mice. Nude (C57BL/6 BALB/c)Fa mice that were reconstituted with thymus grafts of only one parent (Table I, exp. 2) generated virus-immune T cells that were restricted to the H-2 type of the thymus donor alone. This was invariably true as well for nude F mice reconstituted with thymus grafts from both parents but retaining only one histologically functional thymus. As shown in Table I, exp. 2, the restriction specificity expressed by (C57BL/6 BALB/c)F nude mice reconstituted with BALB/c (H-2 d) thymus grafts was significant for infected /-/-2 d targets only. This activity was about one-half of that of the unmanipulated control

ZINKERNAGEL ET AL. BRIEF DEFINITIVE REPORT 695 TABLE I Restriction Specificities of Virus-specific Cytotoxic T Cells from (C57BL/6 X BALB/c)Fa NU/NU Mice Reconstituted with Fetal Thymus Grufls from One or Both Parental Strains* Recipient nu/nu Thymus donors Percentage of specific release Ratio of spleen from infected target cells:}: cells to target H.2 a H.2 b cells (D2) (MC57G) Exp. (C57BL BALB/c)F, [BALB/c (t-2 d) l 0 ~] (H-2 b x H-2 a) ~plus C57BL (H-2b)~ 3 Controls (a) C57BL 0 3 3 5 (b) BALB/c 0 ~ 0 3 ~ 0 0 Exp. 2 Vacc. Nor. Vacc. Nor. (C57BL X BALB/c)F~ BALB/c (H-2 a) 03 [~] 3 []3 2 (C57BL x BALB/c)F~ C57BL (H-2 b) Controls (a) C57BL (b) BALB/c W 5 2 0 0 8 ~ 0 3 7 8 5 ]227[ 0 0 0 [-~ 0 3 5 0 ~ 0 0 5 0 0 ~ 3 3 3 [388~ 2 0 Vacc., vaccine; Nor., normal. * Recipient (C57BL/6 BALB/c)F~ nu/nu mice were transplanted with 5- to 8-d fetal thymus lobes under the kidney capsule. 8-0 wk later the thymus chimeras were infected intravenously with ~5 l06 plaque-forming units of vaccinia virus. 6 d later the mice were killed; their spleen cells were tested for cytotoxic activity, and H-2 type (>95% of Fu origin), and the thymus grafts were examined histologically. :~ '~lcr-release test conditions. Exp. : test duration 6 h; spontaneous release from infected D2:37%; from infected MC57G: 3%. Exp. 2: test duration 6 h; spontaneous release from infected D2:8% from infected MC57G:2%. Results that are significantly greater than those obtained by normal or histoincompatible immune spleen cells are boxed ( P < 0.05). mice and was at least 20-30 times greater on infected H-2 d targets than on infected H-2 b targets. The lytic activity of spleen cells from F nu/nu mice with a BALB/c thymus on infected H-2 b targets was very low, although definitely greater than spleen cells from unmanipulated BALB/c (H-2 d) mice; but this small activity was of questionable significance because both infected and uninfected targets were lysed. In the symmetrical combination, in which C57BL/6 (H-2~ thymus lobes reconstituted F nudes, spleen cell activity was again >30 times greater on syngeneic infected H-2 b targets than on the infected thymus-incompatible H-2 a targets. In this case the ~lcr release by control spleen cells from C57BL mice on infected H-2 d targets was similar to that by chimeric lymphocytes, and both chimeric and control mice lysed uninfected targets to similar extents. The present results confirm, in thymus-reconstituted nude mice, our and Bevan's earlier experiments in irradiation bone marrow and indicate that suppression does not explain the apparent thymic selection oft cells' restriction specificity in chimeras. These results are also in agreement with the finding that nude F mice reconstituted

696 ZINKERNAGEL ET AL. BRIEF DEFINITIVE REPORT with thymus grafts from the parent that responds to collagen will, whereas those reconstituted with thymuses from the nonresponder parent will not, respond to collagen with an IgG response (2). Our data confirm the finding (3-6) that the restriction of primary virus-specific cytotoxic T cells from H-2 a - H-2 b chimeras is, if experiments are thoroughly controlled (5), of comparable specificity as that expressed by unmanipulated control mice. It is clear that all immunological specificity is relative; therefore restriction specificity of eytotoxic T cells cannot be absolute. In fact, it has been shown that lymphocytes from H-2-incompatible irradiation bone marrow chimeras may express cytotoxic activities restricted to the tolerated H-2, that was not expressed in the thymus, upon secondary or tertiary restimulation against minor histocompatibility antigens (6). These and comparably highly selective experiments involving negative filtration of lymphocytes through irradiated allogeneic recipients to eliminate alloreactivity and subsequent sensitization against antigens presented together with the same alloantigens (7, 8, see also 9) cannot be used to compare or quantitate relevant precursor cells. Therefore, results of this type do not distinguish between the two models of T-cell recognition: a single receptor, for a neoantigenic determinant formed between selfoh and foreign antigens versus two receptor sites, one for self-h and one for foreign antigen. As shown previously in thymus or irradiation bone marrow chimeras (3-8), in negative selection experiments (8) and here, it is remarkable that the degree of restriction in primary antiviral responses by thymic chimeras is comparable to that by normal mice. Our results are from chimeras in which antigen presentation is optimal in association with both H-2 haplotypes involved in a given chimera; they reflect restricted T-cell activity generated during an acute primary antiviral response in vivo. In absence of a reliable assay to estimate the relative frequency of precursor cells in a defined in vitro system, the relative activity found in these chimeras, where no selection should occur at the level of sensitization, gives the best estimate of relative precursor frequencies we can obtain. T-cell activity, restricted to the thymic H-2, is at least 30- to 50-fold greater than for the second parental H-2 type that is not expressed in the thymus. This does not, however, exclude the possible presence of rare precursor T cells that may be restricted (by cross-reactivity?) to the MHC type absent from the thymus and may be boosted under selective conditions to become measurable (20). We therefore feel, to understand the general principles of T-cell restriction and recognition, it is more important to further analyze and understand the high frequency of T cells that are restricted to thymic MHC rather than to generalize from a rare exception. Received for publication 26 March 979. References. Davies, A. J. S. 969. The thymus and the cellular basis of immunity. Transplant. Rev. :3. 2. Miller, J. F. A. P., and D. Osoba. 967. Current concepts of the immunological function of the thymus. Physiol. Rev. 7:37. 3. Bevan, M. J. 977. In a radiation chimera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells. Nature (Lond.). 269:7.. Zinkernagel, R. M., G. N. Callahan, A. Ahhage, J. Cooper, P. A. Klein, andj. Klein. 978. On the thymus in the differentiation of "H-2 self-recognition" by T cells: Evidence for dual recognition? J. Exp. Med. 7:882.

ZINKERNAGEL ET AL. BRIEF DEFINITIVE REPORT 697 5. Bevan, M. J,, and P. J. Fink. 978. The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells. Immunol. Rev. 2:. 6. Zinkernagel, R. M. 978. Thymus and lymphohemopoietic cells: their role in T cell maturation in selection of T cells' H-2-restriction-specificity and in H-2 linked Ir gene control. Immunol. Rev. 2:22. 7. Waldmann, H., Pope, H., Bettles, C., and Davies, A. J. S. 979. The influence of thymus on the development of MHC restrictions exhibited by T helper cells. Nature (Lond.). 277: 35. 8. Miller, J. F. A. P., J. Gamble, P. Mottram, and F. I. Smith. 979. Influence of thymus genotype on acquisition of responsiveness in delayed-type hypersensitivity. Scand.J. Immunol. 9:29. 9. Kindred, B., and F. Loor. 97. Activity of host-derived T cells which differentiate in nude mice grafted with co-isogenic or allogenic thymuses.j. Exp. Med. 39:25. 0. Reid, L. M., J. Holland, C. Jones, B. Wolf, G. Niwayama, R. Williams, N. O. Kaplan, and G. Sato. 978. Some of the variables affecting the success of transplantation of human tumors into the athymic nude mouse. In Proceedings Symposium on the Use of Athymic (Nude) Mice in Cancer Research. 07.. Watson, J., R. Epstein, I. Nakoinz, and P. Ralph. 973. The role of normal factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. J. Immunol. 0:3-52. 2. Hedrick, S. M., and Watson, J. 979. Genetic control of the immune response to collagen. II. Antibody responses produced in fetal liver restored radiation chimeras and thymus reconstituted F hybrid nude mice. J. Exp. Med. 50: In press. 3. Zinkernagel, R. M., A. Althage, S. Cooper, G. N. Callahan, and J. Klein. 978. In irradiation chimeras, K or D regions of the chimeric host, not of the donor lymphocytes determine immune responsiveness of antiviral cytotoxic T cells. J. Exp. Med. 8:805.. Callahan, G. N., S. Ferrone, M. D. Poulik, R. A. Reisfeld, and J. Klein. 976. Characterization of Ia antigens in mouse serum.j. Immunol. 7:35. 5. Blanden, R. V., and M. E. Andrew. 979. Primary anti-viral cytotoxic T-cell responses in semiallogeneic chimeras are not absolutely restricted to host H-2 type. J. Exp. Med. 9: 535. 6. Matzinger, P., and G. Mirkwood. 978. In a fully H-2 incompatible chimera, T cells of donor origin can respond to minor histocompatibility antigens in association with either donor or host H-2 type.j. Exp. Med. 8:8. 7. Wilson, D. B., K. F. Lindahl, D. H. Wilson, andj. Sprent. 977. The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens.j. Exp. Med. 6:36. 8. Bennink, J. R., and P. C. Doherty. 978. T-cell populations specifically depleted of altoreactive potential cannot be induced to lyse H-2-different virus-infected target cells. J. Exp. Med. 8:28. 9. Bevan, M.J. 977. Killer cells reactive to altered-self antigens can also be alloreactive. Proc. Natl. Acad. Sci. U. S. A. 7:209. 20. Doherty, P. C., and J. R. Bennink. 979. Vaccinia-specific eytotoxic T-cell responses in the context of H-2 antigens not encountered in thymus may reflect aberrant recognition of a virus-h-2 complex.j. Exp. Med. 9:50.